Vaxcyte, Inc. — Director's Dealing 2022

Oct 13, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2022-10-11

Reporting Person: Fairman Jeff (VP, Research)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-11	Common Stock	S	5000	$25.50	Disposed	296227	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17143	Direct
Common Stock	50000	Indirect

Footnotes

F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.